It’s been over a year since the COVID-19 pandemic struck the world with full force, and the battle is still ongoing with new fast-spreading variants and renewed lockdown measures. The devastation of the pandemic causing millions of deaths, economic strife, financial burden, and social constraints marked a significant effect on the mental health of people
According to a scientific paper published in the European Journal of Human Genetics, approx. 300 million people (around 3.5-5.9%) are living with rare diseases, out of which 72% are genetic, and of those 70% start in childhood. A greater understanding of biology with the rapid adoption of revolutionary diagnostic and therapeutic technologies has unlocked treatment options for people with rare diseases. Many
Amongst 30 million Americans diagnosed with diabetes, about 1.4 million Type-1 Diabetes patients require insulin lifelong to manage their condition, but affordability is a great concern. Insulin prices have increased up to 1200% since 1996, even though the formulations have largely remained the same. The cost of insulins is ten times more in the USA than in any other developed country.
Increasing number of COVID-19 patients across the globe to drive the growth of global remdesivir market. According to TechSci Research report, “Global Remdesivir Market By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and
Advancing biotechnological research is driving the growth in Global Nanopore Sequencing Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Nanopore Sequencing Market By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), By Type of
Advancing healthcare industry is driving the growth in Global Psychobiotics Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application
Advancing healthcare industry drives the Asia-Pacific Active Pharmaceutical Ingredient Market growth in the forecast period, 2022-2026F. According to TechSci Research report, “Asia-Pacific Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s Synthetic) By Source (Contact Manufacturing Organizations v/s In-House Manufacturing) By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others) By Molecule
Easier travel policies are driving the growth of Saudi Arabia Medical Tourism Market, in the forecast period, 2022-2026. According to TechSci report on, “Saudi Arabia Medical Tourism Market By Type (Inbound v/s Outbound) By Treatment Type (Orthopedic Treatment, Gynecological Treatment, Pediatric Treatment, Dental Treatment, Fertility Treatment, Cosmetic Treatment, Others) By Region, Competition Forecast & Opportunities, 2026”, Saudi
Increasing health concerns post COVID infection is driving the growth if India Post COVID Health Tests Market, FY2017-FY2027. According to TechSci report on, “India Post COVID Health Tests Market By Type of Test (COVID-19 IgG Antibody Test, Hematology, Biochemistry Urea & Electrolytes, Liver Function Tests, Kidney Function Tests, Others) By Provider Type (Hospitals, Diagnostic chains, Stand-alone
Increasing disease burden is expected to drive the demand for the India diagnostic labs market. According to TechSci Research report, “India Diagnostic Labs Market By Provider Type (Stand-Alone Labs, Hospital Labs, Diagnostic Chains), By Test Type (Pathology v/s Radiology), By Sector (Urban v/s Rural), By End User (Referrals, Walk-ins, Corporate Clients), By Region, Competition Forecast & Opportunities,
